151 related articles for article (PubMed ID: 37984892)
1. Building up a genomic surveillance platform for SARS-CoV-2 in the middle of a pandemic: a true North-South collaboration.
Khan W; Kabir F; Kanwar S; Aziz F; Muneer S; Kalam A; Rajab Ali MN; Ansari N; Vanaerschot M; Ahyong V; Fahsbender L; Kalantar K; Black A; Glascock A; Gil J; Ayscue P; Tato C; Jehan F; Nisar I
BMJ Glob Health; 2023 Nov; 8(11):. PubMed ID: 37984892
[TBL] [Abstract][Full Text] [Related]
2. Genomic surveillance during the first two years of the COVID-19 pandemic - country experience and lessons learned from Türkiye.
Yalçın S; Coşgun Y; Dedeoğlu E; Kopp K; Bayrakdar F; Ünal G; Musul B; Sağtaş E; Korukluoğlu G; Raftery P; Kaygusuz S
Front Public Health; 2024; 12():1332109. PubMed ID: 38855447
[TBL] [Abstract][Full Text] [Related]
3. Global disparities in SARS-CoV-2 genomic surveillance.
Brito AF; Semenova E; Dudas G; Hassler GW; Kalinich CC; Kraemer MUG; Ho J; Tegally H; Githinji G; Agoti CN; Matkin LE; Whittaker C; ; ; ; ; ; ; ; ; Howden BP; Sintchenko V; Zuckerman NS; Mor O; Blankenship HM; de Oliveira T; Lin RTP; Siqueira MM; Resende PC; Vasconcelos ATR; Spilki FR; Aguiar RS; Alexiev I; Ivanov IN; Philipova I; Carrington CVF; Sahadeo NSD; Branda B; Gurry C; Maurer-Stroh S; Naidoo D; von Eije KJ; Perkins MD; van Kerkhove M; Hill SC; Sabino EC; Pybus OG; Dye C; Bhatt S; Flaxman S; Suchard MA; Grubaugh ND; Baele G; Faria NR
Nat Commun; 2022 Nov; 13(1):7003. PubMed ID: 36385137
[TBL] [Abstract][Full Text] [Related]
4. SARS-CoV-2 genomic epidemiology: data and sequencing infrastructure.
Merhi G; Koweyes J; Salloum T; Khoury CA; Haidar S; Tokajian S
Future Microbiol; 2022 Sep; 17():1001-1007. PubMed ID: 35899481
[TBL] [Abstract][Full Text] [Related]
5. Two Years of Genomic Surveillance in Belgium during the SARS-CoV-2 Pandemic to Attain Country-Wide Coverage and Monitor the Introduction and Spread of Emerging Variants.
Cuypers L; Dellicour S; Hong SL; Potter BI; Verhasselt B; Vereecke N; Lambrechts L; Durkin K; Bours V; Klamer S; Bayon-Vicente G; Vael C; Ariën KK; De Mendonca R; Soetens O; Michel C; Bearzatto B; Naesens R; Gras J; Vankeerberghen A; Matheeussen V; Martens G; Obbels D; Lemmens A; Van den Poel B; Van Even E; De Rauw K; Waumans L; Reynders M; Degosserie J; ; Maes P; André E; Baele G
Viruses; 2022 Oct; 14(10):. PubMed ID: 36298856
[TBL] [Abstract][Full Text] [Related]
6. Implementation of California COVIDNet - a multi-sector collaboration for statewide SARS-CoV-2 genomic surveillance.
Wadford DA; Baumrind N; Baylis EF; Bell JM; Bouchard EL; Crumpler M; Foote EM; Gilliam S; Glaser CA; Hacker JK; Ledin K; Messenger SL; Morales C; Smith EA; Sevinsky JR; Corbett-Detig RB; DeRisi J; Jacobson K
Front Public Health; 2023; 11():1249614. PubMed ID: 37937074
[TBL] [Abstract][Full Text] [Related]
7. Study of the SARS-CoV-2 genomic data generation to evaluate the introduction of genomics in epidemiological surveillance and public health decision making.
Souho T; Lamboni L; Bakadia BM; Taale E; Palanga KK; Amouzou SK
Pan Afr Med J; 2022; 41():55. PubMed ID: 35317482
[TBL] [Abstract][Full Text] [Related]
8. An appeal for strengthening genomic pathogen surveillance to improve pandemic preparedness and infection prevention: the German perspective.
Salzberger B; Mellmann A; Bludau A; Ciesek S; Corman V; Dilthey A; Donker T; Eckmanns T; Egelkamp R; Gatermann SG; Grundmann H; Häcker G; Kaase M; Lange B; Mielke M; Pletz MW; Semmler T; Thürmer A; Wieler LH; Wolff T; Widmer AF; Scheithauer S
Infection; 2023 Aug; 51(4):805-811. PubMed ID: 37129842
[TBL] [Abstract][Full Text] [Related]
9. Challenges of SARS-CoV-2 genomic surveillance in India during low positivity rate scenario.
Tomar SS; Khairnar K
Front Public Health; 2023; 11():1117602. PubMed ID: 37441634
[TBL] [Abstract][Full Text] [Related]
10. Strengthening pathogen genomic surveillance for health emergencies: insights from the World Health Organization's regional initiatives.
Akande OW; Carter LL; Abubakar A; Achilla R; Barakat A; Gumede N; Guseinova A; Inbanathan FY; Kato M; Koua E; Leite J; Marklewitz M; Mendez-Rico J; Monamele C; Musul B; Nahapetyan K; Naidoo D; Ochola R; Ozel M; Raftery P; Vicari A; Wijesinghe PR; Zwetyenga J; Safreed-Harmon K; Barnadas C; Mulders M; Pereyaslov DI; Sacks JA; Warren T; Cognat S; Briand S; Samaan G
Front Public Health; 2023; 11():1146730. PubMed ID: 37361158
[TBL] [Abstract][Full Text] [Related]
11. Genomic surveillance of SARS-CoV-2 evolution by a centralised pipeline and weekly focused sequencing, Austria, January 2021 to March 2023.
Frank O; Balboa DA; Novatchkova M; Özkan E; Strobl MM; Yelagandula R; Albanese TG; Endler L; Amman F; Felsenstein V; Gavrilovic M; Acosta M; Patocka T; Vogt A; Tamir I; Klikovits J; Zoufaly A; Seitz T; Födinger M; Bergthaler A; Indra A; Schmid D; Klimek P; Stark A; Allerberger F; Benka B; Reich K; Cochella L; Elling U
Euro Surveill; 2024 Jun; 29(23):. PubMed ID: 38847119
[TBL] [Abstract][Full Text] [Related]
12. Mobilisation and analyses of publicly available SARS-CoV-2 data for pandemic responses.
Rahman N; O'Cathail C; Zyoud A; Sokolov A; Oude Munnink B; Grüning B; Cummins C; Amid C; Nieuwenhuijse DF; Visontai D; Yuan DY; Gupta D; Prasad DK; Gulyás GM; Rinck G; McKinnon J; Rajan J; Knaggs J; Skiby JE; Stéger J; Szarvas J; Gueye K; Papp K; Hoek M; Kumar M; Ventouratou MA; Bouquieaux MC; Koliba M; Mansurova M; Haseeb M; Worp N; Harrison PW; Leinonen R; Thorne R; Selvakumar S; Hunt S; Venkataraman S; Jayathilaka S; Cezard T; Maier W; Waheed Z; Iqbal Z; Aarestrup FM; Csabai I; Koopmans M; Burdett T; Cochrane G
Microb Genom; 2024 Feb; 10(2):. PubMed ID: 38358325
[TBL] [Abstract][Full Text] [Related]
13. Pathogen genomics in public health laboratories: successes, challenges, and lessons learned from California's SARS-CoV-2 Whole-Genome Sequencing Initiative, California COVIDNet.
Smith EA; Libuit KG; Kapsak CJ; Scribner MR; Wright SM; Bell J; Morales C; Crumpler M; Messenger S; Hacker JK; Ledin K; Glaser C; Jacobson K; Sevinsky JR; Wadford DA
Microb Genom; 2023 Jun; 9(6):. PubMed ID: 37267020
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatic investigation of discordant sequence data for SARS-CoV-2: insights for robust genomic analysis during pandemic surveillance.
Zufan SE; Lau KA; Donald A; Hoang T; Foster CSP; Sikazwe C; Theis T; Rawlinson WD; Ballard SA; Stinear TP; Howden BP; Jennison AV; Seemann T
Microb Genom; 2023 Nov; 9(11):. PubMed ID: 38019123
[TBL] [Abstract][Full Text] [Related]
15. Pakistan's COVID-19 Outbreak Preparedness and Response: A Situational Analysis.
Noreen N; Rehman SAU; Naveed I; Niazi SUK; Furqan IB
Health Secur; 2021 Nov; 19(6):605-615. PubMed ID: 34762516
[TBL] [Abstract][Full Text] [Related]
16. Genomic Epidemiology and Lineage Dynamics of SARS-CoV-2 in Bulgaria: Insights from a Three-Year Pandemic Analysis.
Giovanetti M; Cella E; Ivanov I; Grigorova L; Stoikov I; Donchev D; Dimitrova R; Slavov SN; Mavian C; Fonseca V; Scarpa F; Borsetti A; Korsun N; Trifonova I; Dobrinov V; Kantardjiev T; Christova I; Ciccozzi M; Alexiev I
Viruses; 2023 Sep; 15(9):. PubMed ID: 37766330
[TBL] [Abstract][Full Text] [Related]
17. Phylogenomic early warning signals for SARS-CoV-2 epidemic waves.
Drake KO; Boyd O; Franceschi VB; Colquhoun RM; Ellaby NAF; Volz EM
EBioMedicine; 2024 Feb; 100():104939. PubMed ID: 38194742
[TBL] [Abstract][Full Text] [Related]
18. Tracking SARS-CoV-2 introductions in Mozambique using pandemic-scale phylogenies: a retrospective observational study.
Martínez-Martínez FJ; Massinga AJ; De Jesus Á; Ernesto RM; Cano-Jiménez P; Chiner-Oms Á; Gómez-Navarro I; Guillot-Fernández M; Guinovart C; Sitoe A; Vubil D; Bila R; Gujamo R; Enosse S; Jiménez-Serrano S; Torres-Puente M; Comas I; Mandomando I; López MG; Mayor A
Lancet Glob Health; 2023 Jun; 11(6):e933-e941. PubMed ID: 37202028
[TBL] [Abstract][Full Text] [Related]
19. Global SARS-CoV-2 genomic surveillance: What we have learned (so far).
Tosta S; Moreno K; Schuab G; Fonseca V; Segovia FMC; Kashima S; Elias MC; Sampaio SC; Ciccozzi M; Alcantara LCJ; Slavov SN; Lourenço J; Cella E; Giovanetti M
Infect Genet Evol; 2023 Mar; 108():105405. PubMed ID: 36681102
[TBL] [Abstract][Full Text] [Related]
20. Investing in health preparedness, response and resilience: a genomics costing tool focused on next generation sequencing.
Akande OW; Afrough B; Amante M; Carter L; Cunningham J; Hull NC; Inamdar L; Jaguparov A; Marklewitz M; Musul B; Norberg A; Pereyaslov DI; Poates AL; Samaan G; Suresh A; Uplekar S; Wilhem A; Salvi Le Garrec Zwetyenga J; Whistler T
Front Public Health; 2024; 12():1404243. PubMed ID: 38784596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
